The study on the Geratherm Group published by AlsterResearch on July 21, 2022 and the determined price target of EUR 11.00 have now been raised to EUR 11.30 following an update on 09/21/2022. The main reason for this was the successful second quarter of the Geratherm Group.
Via Research Hub, investors get free access to the update of Geratherm Medical's digital coverage.
Alternatively, you can find the update as a PDF file here.
